{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:08:14Z","timestamp":1761523694296},"reference-count":36,"publisher":"FapUNIFESP (SciELO)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. braz j urol."],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1590\/1677-553820133806739","type":"journal-article","created":{"date-parts":[[2014,5,12]],"date-time":"2014-05-12T13:00:49Z","timestamp":1399899649000},"page":"739-749","source":"Crossref","is-referenced-by-count":10,"title":["Downregulation of C3 and C4A\/B complement factor fragments in plasma from patients with squamous cell carcinoma of the penis"],"prefix":"10.1590","volume":"38","author":[{"given":"Paulo","family":"Ornellas","sequence":"first","affiliation":[{"name":"Hematology Service (PO, DAP, VS, ASC, GA)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio Augusto","family":"Ornellas","sequence":"additional","affiliation":[{"name":"Hematology Service (PO, DAP, VS, ASC, GA)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clizia","family":"Chinello","sequence":"additional","affiliation":[{"name":"Hematology Service (PO, DAP, VS, ASC, GA)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica","family":"Gianazza","sequence":"additional","affiliation":[{"name":"Hematology Service (PO, DAP, VS, ASC, GA)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronica","family":"Mainini","sequence":"additional","affiliation":[{"name":"Hematology Service (PO, DAP, VS, ASC, GA)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Cazzaniga","sequence":"additional","affiliation":[{"name":"Hematology Service (PO, DAP, VS, ASC, GA)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise Abreu","family":"Pereira","sequence":"additional","affiliation":[{"name":"Hematology Service (PO, DAP, VS, ASC, GA)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Sandim","sequence":"additional","affiliation":[{"name":"Hematology Service (PO, DAP, VS, ASC, GA)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Sheila","family":"Cypriano","sequence":"additional","affiliation":[{"name":"Hematology Service (PO, DAP, VS, ASC, GA)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leandro","family":"Koifman","sequence":"additional","affiliation":[{"name":"Hematology Service (PO, DAP, VS, ASC, GA)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulo Cesar Barbosa da","family":"Silva","sequence":"additional","affiliation":[{"name":"Hematology Service (PO, DAP, VS, ASC, GA)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilda","family":"Alves","sequence":"additional","affiliation":[{"name":"Hematology Service (PO, DAP, VS, ASC, GA)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fulvio","family":"Magni","sequence":"additional","affiliation":[{"name":"Hematology Service (PO, DAP, VS, ASC, GA)"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S1470-2045(04)01427-5","article-title":"Penile carcinoma: a challenge for the developing world","volume":"5","author":"Misra S","year":"2004","journal-title":"Lancet Oncol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/jso.20980","article-title":"Surgical treatment of invasive squamous cell carcinoma of the penis: Brazilian National Cancer Institute long-term experience","volume":"97","author":"Ornellas AA","year":"2008","journal-title":"J Surg Oncol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/j.1464-410X.1993.tb16273.x","article-title":"Correlation between the extent of nodal involvement and survival following groin dissection for carcinoma of the penis","volume":"72","author":"Ravi R","year":"1993","journal-title":"Br J Urol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1023\/A:1008248319036","article-title":"Squamous cell carcinoma of the penis: multivariate analysis of prognostic factors and natural history in monocentric study with a conservative policy","volume":"8","author":"Soria JC","year":"1997","journal-title":"Ann Oncol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0022-5347(05)64836-7","article-title":"p53 as a new prognostic factor for lymph node metastasis in penile carcinoma: analysis of 82 patients treated with amputation and bilateral lymphadenectomy","volume":"168","author":"Lopes A","year":"2002","journal-title":"J Urol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.juro.2008.06.028","article-title":"Prognostic factors in invasive squamous cell carcinoma of the penis: analysis of 196 patients treated at the Brazilian National Cancer Institute","volume":"180","author":"Ornellas AA","year":"2008","journal-title":"J Urol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0094-0143(21)00394-3","article-title":"Controversies in ilioinguinal lymphadenectomy for cancer of the penis","volume":"19","author":"Abi-Aad AS","year":"1992","journal-title":"Urol Clin North Am"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.injury.2006.11.021","article-title":"Application of clinical proteomics in diagnosis and management of trauma patients","volume":"38","author":"Alpantaki K","year":"2007","journal-title":"Injury"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S1470-2045(06)70584-8","article-title":"Discovery and validation of new protein biomarkers for urothelial cancer: a prospective analysis","volume":"7","author":"Theodorescu D","year":"2006","journal-title":"Lancet Oncol"},{"key":"ref10","series-title":"Cancer Proteomics From Bench to Bedside","first-page":"121","volume-title":"Insight on renal cell carcinoma proteome","author":"Sarto C","year":"2008"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.copbio.2004.01.005","article-title":"SELDI-TOF-based serum proteomic pattern diagnostics for early detection of cancer","volume":"15","author":"Petricoin EF","year":"2004","journal-title":"Curr Opin Biotechnol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1002\/prca.200780139","article-title":"Human urine biomarkers of renal cell carcinoma evaluated by ClinProt","volume":"2","author":"Bosso N","year":"2008","journal-title":"Proteomics Clin Appl"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/pmic.200500033","article-title":"Differential detection of S100A8 in transitional cell carcinoma of the bladder by pair wise tissue proteomic and immunohistochemical analysis","volume":"6","author":"Tolson JP","year":"2006","journal-title":"Proteomics"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.clinbiochem.2006.08.010","article-title":"Increase diagnostic efficacy by combined use of finger-print markers in mass spectrometry--plasma peptidomes from nasopharyngeal cancer patients for example","volume":"39","author":"Chang JT","year":"2006","journal-title":"Clin Biochem"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/MLG.0b013e31814cf389","article-title":"Differential capture of serum proteins for expression profiling and biomarker discovery in pre- and posttreatment head and neck cancer samples","volume":"118","author":"Freed GL","year":"2008","journal-title":"Laryngoscope"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.urology.2009.09.050","article-title":"Serum biomarkers of renal cell carcinoma assessed using a protein profiling approach based on ClinProt technique","volume":"75","author":"Chinello C","year":"2010","journal-title":"Urology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2144\/05386SU07","article-title":"Fishing for biomarkers: analyzing mass spectrometry data with the new ClinProTools software","volume":"(Suppl)","author":"Ketterlinus R","year":"2005","journal-title":"Biotechniques"},{"key":"ref18","author":"Holland JH","year":"1975"},{"key":"ref19","first-page":"1","author":"Vapnik V","year":"1998"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1126\/science.3287615","article-title":"Measuring the accuracy of diagnostic systems","volume":"240","author":"Swets JA","year":"1988","journal-title":"Science"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1590\/S1677-55382008000400009","article-title":"Human papillomavirus and penile cancers in Rio de Janeiro, Brazil: HPV typing and clinical features","volume":"34","author":"Scheiner MA","year":"2008","journal-title":"Int Braz J Urol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00345-008-0275-y","article-title":"Molecular prognostic factors in penile cancer","volume":"27","author":"Muneer A","year":"2009","journal-title":"World J Urol"},{"key":"ref23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013133","article-title":"Blood peptidome-degradome profile of breast cancer","volume":"5","author":"Shen Y","year":"2010","journal-title":"PLoS One"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.imlet.2007.04.014","article-title":"Complement as effector system in cancer immunotherapy","volume":"111","author":"Macor P","year":"2007","journal-title":"Immunol Lett"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1477-5956-9-5","article-title":"Plasma peptidome profiling of acute hepatitis E patients by MALDI-TOF\/TOF","volume":"9","author":"Taneja S","year":"2011","journal-title":"Proteome Sci"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1590\/S0074-02762012000100003","article-title":"Prevalence of human papillomavirus and Epstein-Barr virus DNA in penile cancer cases from Brazil","volume":"107","author":"Afonso LA","year":"2012","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.virol.2010.07.044","article-title":"HPV-16 E5 down-regulates expression of surface HLA class I and reduces recognition by CD8 T cells","volume":"407","author":"Campo MS","year":"2010","journal-title":"Virology"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"16666","DOI":"10.1074\/jbc.M001123200","article-title":"Factor H binding to bone sialoprotein and osteopontin enables tumor cell evasion of complement-mediated attack","volume":"275","author":"Fedarko NS","year":"2000","journal-title":"J Biol Chem"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1007\/s00262-003-0402-y","article-title":"Enhanced expression of the complement regulatory protein CD55 predicts a poor prognosis in colorectal cancer patients","volume":"52","author":"Durrant LG","year":"2003","journal-title":"Cancer Immunol Immunother"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/labinvest.3780038","article-title":"A possible role of CD46 for the protection in vivo of human renal tumor cells from complement-mediated damage","volume":"80","author":"Blok VT","year":"2000","journal-title":"Lab Invest"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1159\/000069451","article-title":"Clinical implications of natural killer cytotoxicity in patients with squamous cell carcinoma of the penis","volume":"16","author":"Campos MM","year":"1998","journal-title":"Nat Immun"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ni1102-991","article-title":"Cancer immunoediting: from immunosurveillance to tumor escape","volume":"3","author":"Dunn GP","year":"2002","journal-title":"Nat Immunol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-2776(06)90001-7","article-title":"Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity","volume":"90","author":"Smyth MJ","year":"2006","journal-title":"Adv Immunol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1080\/08820130600754994","article-title":"Leukocyte infiltration in cancer creates an unfavorable environment for antitumor immune responses: a novel target for therapeutic intervention","volume":"35","author":"Bronte V","year":"2006","journal-title":"Immunol Invest"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1146\/annurev.immunol.25.022106.141609","article-title":"Immunosuppressive strategies that are mediated by tumor cells","volume":"25","author":"Rabinovich GA","year":"2007","journal-title":"Annu Rev Immunol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/nri1936","article-title":"Cancer despite immunosurveillance: immunoselection and immunosubversion","volume":"6","author":"Zitvogel L","year":"2006","journal-title":"Nat Rev Immunol"}],"container-title":["International braz j urol"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/ibju\/v38n6\/1677-5538-ibju-38-06-739.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T12:35:21Z","timestamp":1648989321000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S1677-55382012000600739&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S1677-55382012000600739"],"URL":"https:\/\/doi.org\/10.1590\/1677-553820133806739","relation":{},"ISSN":["1677-5538"],"issn-type":[{"value":"1677-5538","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}